Chris Savoie

Chief Executive Officer | Co-Founder

Mr. Savoie is a world traveler and entrepreneur who began his work with medical cannabis in 2004 under the now repealed Medical Marihuana for Medical Purposes Regulations (Canada)(“MMMR”), enacted under Controlled Drugs and Substances Act (S.C. 1996, c. 19). While working full time in sales and project management, he built a wealth of knowledge as a cannabis grower and cannabis product developer, working to relieve his father’s multiple sclerosis symptoms. His skills in a wide range of extraction methodologies and experience selecting phenotypes with ideal characteristics for those processes have been integral to the development of several award winning legacy medical cannabis brands. Mr. Savoie brings his extensive cannabis expertise, business acumen and powerful industry network to the new era of regulated recreational cannabis extract products.

Tyler Metford

Chief Operations Officer | Co-Founder

Mr. Metford’s background in technology has made him a critical asset to the diverse projects in which he has been involved. His agility in managing operations, developing systems and products, along with branding and valuable digital assets has allowed him a natural progression through innovative professional roles. Mr. Metford’s expertise has been instrumental to the development of several well-known cannabis-adjacent brands, businesses, and boutique location buildouts, acquainting him with the tastes of other cannabis connoisseurs. Mr. Metford has for many years been a fierce proponent of cannabis therapy, having obtained a cannabis production authorization under the now-repealed Medical Marihuana for Medical Purposes Regulations (Canada)(“MMMR”) in 2011.

Donal Carroll

Chief Financial Officer | Co-Founder

Mr. Carroll has over 15 years of corporate finance leadership and public company experience, as well as in-depth experience in syndicated investments in equity and debt securities. Throughout his career with Danaher Corporation, Unilever PLC, and Cardinal Meat Specialists Ltd., Mr. Carroll was instrumental in major restructuring activities, mergers and acquisitions, and the implementation of new internal controls and enterprise resource planning systems. Mr. Carroll is the former Chief Financial Officer of FSD Pharma Inc. (CSE: HUGE). He also serves as Director of Bird River Resources Inc., a natural resources company focused on the energy sector. Mr. Carroll holds a CPA-CMA designation as well as a Bachelor of Commerce degree from University College, Dublin.

Investor Contact

invest@hashco.ca  |  (+1) 647 948 6966